The Impact of Uremic Toxicity Induced Inflammatory Response on the Cardiovascular Burden in Chronic Kidney Disease

Uremic toxin (UT) retention in chronic kidney disease (CKD) affects biological systems. We aimed to identify the associations between UT, inflammatory biomarkers and biomarkers of the uremic cardiovascular response (BUCVR) and their impact on cardiovascular status as well as their roles as predictor...

Full description

Bibliographic Details
Main Authors: Ligia Maria Claro, Andrea N. Moreno-Amaral, Ana Carolina Gadotti, Carla J. Dolenga, Lia S. Nakao, Marina L.V. Azevedo, Lucia de Noronha, Marcia Olandoski, Thyago P. de Moraes, Andréa E. M. Stinghen, Roberto Pécoits-Filho
Format: Article
Language:English
Published: MDPI AG 2018-09-01
Series:Toxins
Subjects:
Online Access:http://www.mdpi.com/2072-6651/10/10/384
_version_ 1798042128197091328
author Ligia Maria Claro
Andrea N. Moreno-Amaral
Ana Carolina Gadotti
Carla J. Dolenga
Lia S. Nakao
Marina L.V. Azevedo
Lucia de Noronha
Marcia Olandoski
Thyago P. de Moraes
Andréa E. M. Stinghen
Roberto Pécoits-Filho
author_facet Ligia Maria Claro
Andrea N. Moreno-Amaral
Ana Carolina Gadotti
Carla J. Dolenga
Lia S. Nakao
Marina L.V. Azevedo
Lucia de Noronha
Marcia Olandoski
Thyago P. de Moraes
Andréa E. M. Stinghen
Roberto Pécoits-Filho
author_sort Ligia Maria Claro
collection DOAJ
description Uremic toxin (UT) retention in chronic kidney disease (CKD) affects biological systems. We aimed to identify the associations between UT, inflammatory biomarkers and biomarkers of the uremic cardiovascular response (BUCVR) and their impact on cardiovascular status as well as their roles as predictors of outcome in CKD patients. CKD patients stages 3, 4 and 5 (n = 67) were recruited and UT (indoxyl sulfate/IS, p-cresil sulfate/pCS and indole-3-acetic acid/IAA); inflammatory biomarkers [Interleukin-6 (IL-6), high sensitivity C reactive protein (hsCRP), monocyte chemoattractant protein-1 (MCP-1), soluble vascular adhesion molecule-1 (sVCAM-1), soluble intercellular adhesion molecule-1 (sICAM-1) and soluble Fas (sFas)] and BUCVRs [soluble CD36 (sCD36), soluble receptor for advanced glycation end products (sRAGE), fractalkine] was measured. Patients were followed for 5.2 years and all causes of death was used as the primary outcome. Artery segments collected at the moment of transplantation were used for the immunohistochemistry analysis in a separate cohort. Estimated glomerular filtration rate (eGFR), circulating UT, plasma biomarkers of systemic and vascular inflammation and BUCVR were strongly interrelated. Patients with plaque presented higher signs of UT-induced inflammation and arteries from CKD patients presented higher fractalkine receptor (CX3CR1) tissue expression. Circulating IS (p = 0.03), pCS (p = 0.007), IL-6 (p = 0.026), sFas (p = 0.001), sCD36 (p = 0.01) and fractalkine (p = 0.02) were independent predictors of total mortality risk in CKD patients. Our results reinforce the important role of uremic toxicity in the pathogenesis of cardiovascular disease (CVD) in CKD patients through an inflammatory pathway.
first_indexed 2024-04-11T22:31:13Z
format Article
id doaj.art-866804be73dc4ec7a5de8f67fe3593f1
institution Directory Open Access Journal
issn 2072-6651
language English
last_indexed 2024-04-11T22:31:13Z
publishDate 2018-09-01
publisher MDPI AG
record_format Article
series Toxins
spelling doaj.art-866804be73dc4ec7a5de8f67fe3593f12022-12-22T03:59:24ZengMDPI AGToxins2072-66512018-09-01101038410.3390/toxins10100384toxins10100384The Impact of Uremic Toxicity Induced Inflammatory Response on the Cardiovascular Burden in Chronic Kidney DiseaseLigia Maria Claro0Andrea N. Moreno-Amaral1Ana Carolina Gadotti2Carla J. Dolenga3Lia S. Nakao4Marina L.V. Azevedo5Lucia de Noronha6Marcia Olandoski7Thyago P. de Moraes8Andréa E. M. Stinghen9Roberto Pécoits-Filho10Graduate Program in Health Sciences, School of Medicine, Pontifícia Universidade Católica do Paraná, Curitiba, PR 80215-901, BrazilGraduate Program in Health Sciences, School of Medicine, Pontifícia Universidade Católica do Paraná, Curitiba, PR 80215-901, BrazilGraduate Program in Health Sciences, School of Medicine, Pontifícia Universidade Católica do Paraná, Curitiba, PR 80215-901, BrazilBasic Pathology Department, Universidade Federal do Paraná, Curitiba, PR 80050-540, BrazilBasic Pathology Department, Universidade Federal do Paraná, Curitiba, PR 80050-540, BrazilGraduate Program in Health Sciences, School of Medicine, Pontifícia Universidade Católica do Paraná, Curitiba, PR 80215-901, BrazilGraduate Program in Health Sciences, School of Medicine, Pontifícia Universidade Católica do Paraná, Curitiba, PR 80215-901, BrazilGraduate Program in Health Sciences, School of Medicine, Pontifícia Universidade Católica do Paraná, Curitiba, PR 80215-901, BrazilGraduate Program in Health Sciences, School of Medicine, Pontifícia Universidade Católica do Paraná, Curitiba, PR 80215-901, BrazilBasic Pathology Department, Universidade Federal do Paraná, Curitiba, PR 80050-540, BrazilGraduate Program in Health Sciences, School of Medicine, Pontifícia Universidade Católica do Paraná, Curitiba, PR 80215-901, BrazilUremic toxin (UT) retention in chronic kidney disease (CKD) affects biological systems. We aimed to identify the associations between UT, inflammatory biomarkers and biomarkers of the uremic cardiovascular response (BUCVR) and their impact on cardiovascular status as well as their roles as predictors of outcome in CKD patients. CKD patients stages 3, 4 and 5 (n = 67) were recruited and UT (indoxyl sulfate/IS, p-cresil sulfate/pCS and indole-3-acetic acid/IAA); inflammatory biomarkers [Interleukin-6 (IL-6), high sensitivity C reactive protein (hsCRP), monocyte chemoattractant protein-1 (MCP-1), soluble vascular adhesion molecule-1 (sVCAM-1), soluble intercellular adhesion molecule-1 (sICAM-1) and soluble Fas (sFas)] and BUCVRs [soluble CD36 (sCD36), soluble receptor for advanced glycation end products (sRAGE), fractalkine] was measured. Patients were followed for 5.2 years and all causes of death was used as the primary outcome. Artery segments collected at the moment of transplantation were used for the immunohistochemistry analysis in a separate cohort. Estimated glomerular filtration rate (eGFR), circulating UT, plasma biomarkers of systemic and vascular inflammation and BUCVR were strongly interrelated. Patients with plaque presented higher signs of UT-induced inflammation and arteries from CKD patients presented higher fractalkine receptor (CX3CR1) tissue expression. Circulating IS (p = 0.03), pCS (p = 0.007), IL-6 (p = 0.026), sFas (p = 0.001), sCD36 (p = 0.01) and fractalkine (p = 0.02) were independent predictors of total mortality risk in CKD patients. Our results reinforce the important role of uremic toxicity in the pathogenesis of cardiovascular disease (CVD) in CKD patients through an inflammatory pathway.http://www.mdpi.com/2072-6651/10/10/384uremic toxinsinflammatory biomarkerssCD36sRAGEfractalkine (CX3CL1)fractalkine receptor (CX3CR1)
spellingShingle Ligia Maria Claro
Andrea N. Moreno-Amaral
Ana Carolina Gadotti
Carla J. Dolenga
Lia S. Nakao
Marina L.V. Azevedo
Lucia de Noronha
Marcia Olandoski
Thyago P. de Moraes
Andréa E. M. Stinghen
Roberto Pécoits-Filho
The Impact of Uremic Toxicity Induced Inflammatory Response on the Cardiovascular Burden in Chronic Kidney Disease
Toxins
uremic toxins
inflammatory biomarkers
sCD36
sRAGE
fractalkine (CX3CL1)
fractalkine receptor (CX3CR1)
title The Impact of Uremic Toxicity Induced Inflammatory Response on the Cardiovascular Burden in Chronic Kidney Disease
title_full The Impact of Uremic Toxicity Induced Inflammatory Response on the Cardiovascular Burden in Chronic Kidney Disease
title_fullStr The Impact of Uremic Toxicity Induced Inflammatory Response on the Cardiovascular Burden in Chronic Kidney Disease
title_full_unstemmed The Impact of Uremic Toxicity Induced Inflammatory Response on the Cardiovascular Burden in Chronic Kidney Disease
title_short The Impact of Uremic Toxicity Induced Inflammatory Response on the Cardiovascular Burden in Chronic Kidney Disease
title_sort impact of uremic toxicity induced inflammatory response on the cardiovascular burden in chronic kidney disease
topic uremic toxins
inflammatory biomarkers
sCD36
sRAGE
fractalkine (CX3CL1)
fractalkine receptor (CX3CR1)
url http://www.mdpi.com/2072-6651/10/10/384
work_keys_str_mv AT ligiamariaclaro theimpactofuremictoxicityinducedinflammatoryresponseonthecardiovascularburdeninchronickidneydisease
AT andreanmorenoamaral theimpactofuremictoxicityinducedinflammatoryresponseonthecardiovascularburdeninchronickidneydisease
AT anacarolinagadotti theimpactofuremictoxicityinducedinflammatoryresponseonthecardiovascularburdeninchronickidneydisease
AT carlajdolenga theimpactofuremictoxicityinducedinflammatoryresponseonthecardiovascularburdeninchronickidneydisease
AT liasnakao theimpactofuremictoxicityinducedinflammatoryresponseonthecardiovascularburdeninchronickidneydisease
AT marinalvazevedo theimpactofuremictoxicityinducedinflammatoryresponseonthecardiovascularburdeninchronickidneydisease
AT luciadenoronha theimpactofuremictoxicityinducedinflammatoryresponseonthecardiovascularburdeninchronickidneydisease
AT marciaolandoski theimpactofuremictoxicityinducedinflammatoryresponseonthecardiovascularburdeninchronickidneydisease
AT thyagopdemoraes theimpactofuremictoxicityinducedinflammatoryresponseonthecardiovascularburdeninchronickidneydisease
AT andreaemstinghen theimpactofuremictoxicityinducedinflammatoryresponseonthecardiovascularburdeninchronickidneydisease
AT robertopecoitsfilho theimpactofuremictoxicityinducedinflammatoryresponseonthecardiovascularburdeninchronickidneydisease
AT ligiamariaclaro impactofuremictoxicityinducedinflammatoryresponseonthecardiovascularburdeninchronickidneydisease
AT andreanmorenoamaral impactofuremictoxicityinducedinflammatoryresponseonthecardiovascularburdeninchronickidneydisease
AT anacarolinagadotti impactofuremictoxicityinducedinflammatoryresponseonthecardiovascularburdeninchronickidneydisease
AT carlajdolenga impactofuremictoxicityinducedinflammatoryresponseonthecardiovascularburdeninchronickidneydisease
AT liasnakao impactofuremictoxicityinducedinflammatoryresponseonthecardiovascularburdeninchronickidneydisease
AT marinalvazevedo impactofuremictoxicityinducedinflammatoryresponseonthecardiovascularburdeninchronickidneydisease
AT luciadenoronha impactofuremictoxicityinducedinflammatoryresponseonthecardiovascularburdeninchronickidneydisease
AT marciaolandoski impactofuremictoxicityinducedinflammatoryresponseonthecardiovascularburdeninchronickidneydisease
AT thyagopdemoraes impactofuremictoxicityinducedinflammatoryresponseonthecardiovascularburdeninchronickidneydisease
AT andreaemstinghen impactofuremictoxicityinducedinflammatoryresponseonthecardiovascularburdeninchronickidneydisease
AT robertopecoitsfilho impactofuremictoxicityinducedinflammatoryresponseonthecardiovascularburdeninchronickidneydisease